3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
6
Head & Neck
2
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
410
Lung Neoplasms
261
Small Cell Lung Carcinoma
75
Colorectal Neoplasms
71
Breast Neoplasms
52
Ovarian Neoplasms
48
Neoplasms
48
Melanoma
48
Pancreatic Neoplasms
45
Neoplasm Metastasis
38
Squamous Cell Carcinoma of Head and Neck
36
Stomach Neoplasms
31
Prostatic Neoplasms
28
Head and Neck Neoplasms
27
Esophageal Neoplasms
26
Carcinoma, Renal Cell
26
Endometrial Neoplasms
25
Colonic Neoplasms
24
Triple Negative Breast Neoplasms
23
Uterine Cervical Neoplasms
22
Urinary Bladder Neoplasms
21
Carcinoma, Hepatocellular
21
Mesothelioma, Malignant
14
Mesothelioma
14
Sarcoma
13
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Lung Diseases
13
Liver Neoplasms
13
Carcinoma, Transitional Cell
13
Thyroid Neoplasms
12
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Thoracic
×
30 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled